Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
The Journal of Physical Chemistry. A|December 8, 2005
Entrainment in a chemical oscillator chain with a pacemakerHirokazu Fukuda, Naoki Tamari, Hiroki Morimura, et al.Journal of Hepatology|May 7, 2014
Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalenceTadashi Inuzuka, Yoshihide Ueda, Hiroki Morimura, et al.Internal Medicine (Tokyo, Japan)|May 10, 2023
Primary Retroperitoneal Mucinous Cystadenocarcinoma during Long-term Administration of Infliximab for the Treatment of Crohn's DiseaseYoshiki Morihisa, Shunji Urai, Hiroyoshi Iwagami, et al.Endoscopy International Open|December 19, 2022
Longly-attached cap can contribute to en bloc underwater endoscopic mucosal resection of 20-30 mm colorectal intramucosal lesionsHiroyoshi Iwagami, Takuji Akamatsu, Shinya Ogino, et al.Internal Medicine (Tokyo, Japan)|April 11, 2022
Primary Hepatic Neuroendocrine Carcinoma with Thrombocytopenia Due to Diffuse Bone Marrow and Splenic Infiltration: An Autopsy CaseShogo Nakano, Kosuke Minaga, Yasuhiro Tani, et al.DEN Open|March 30, 2023
Dexmedetomidine is safe and effective for reducing intraprocedural pain in colorectal endoscopic submucosal dissectionHiroyoshi Iwagami, Takuji Akamatsu, Kazuki Matsuyama, et al.Journal of Gastroenterology|September 17, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective studyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective StudyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Pageof 1